The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Taxol is a chemotherapy medication primarily used to treat various types of cancer. Its active ingredient is paclitaxel, which is derived from the bark of the Pacific yew tree (Taxus brevifolia) or, more commonly, synthesized in the laboratory. Taxol works by interfering with the growth and division of cancer cells. Specifically, it binds to tubulin, a protein involved in cell division, and stabilizes microtubules, preventing them from breaking down. This disruption in microtubule dynamics ultimately leads to cell cycle arrest and apoptosis (programmed cell death) in cancer cells. Taxol is used to treat a variety of cancers, including breast cancer, ovarian cancer, lung cancer, and Kaposi's sarcoma. It is typically administered intravenously by a healthcare professional in a clinical setting. While Taxol can be effective in treating cancer, it may also cause side effects, including hair loss, nausea, vomiting, diarrhea, neuropathy (nerve damage), and bone marrow suppression. The severity and type of side effects experienced can vary from person to person.
The global Taxol market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Taxol is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Taxol is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Taxol include Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Taxol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Taxol.
The Taxol market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Taxol market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Taxol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Segment by Type
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Segment by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Taxol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Taxol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Taxol is a chemotherapy medication primarily used to treat various types of cancer. Its active ingredient is paclitaxel, which is derived from the bark of the Pacific yew tree (Taxus brevifolia) or, more commonly, synthesized in the laboratory. Taxol works by interfering with the growth and division of cancer cells. Specifically, it binds to tubulin, a protein involved in cell division, and stabilizes microtubules, preventing them from breaking down. This disruption in microtubule dynamics ultimately leads to cell cycle arrest and apoptosis (programmed cell death) in cancer cells. Taxol is used to treat a variety of cancers, including breast cancer, ovarian cancer, lung cancer, and Kaposi's sarcoma. It is typically administered intravenously by a healthcare professional in a clinical setting. While Taxol can be effective in treating cancer, it may also cause side effects, including hair loss, nausea, vomiting, diarrhea, neuropathy (nerve damage), and bone marrow suppression. The severity and type of side effects experienced can vary from person to person.
The global Taxol market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Taxol is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Taxol is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Taxol include Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Taxol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Taxol.
The Taxol market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Taxol market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Taxol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Segment by Type
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
Segment by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Taxol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Taxol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Taxol Market Overview
1.1 Product Definition
1.2 Taxol by Type
1.2.1 Global Taxol Market Value Comparison by Type (2024-2030)
1.2.2 Natural Paclitaxel API
1.2.3 Semi-synthetic Paclitaxel API
1.3 Taxol by Application
1.3.1 Global Taxol Market Value by Application (2024-2030)
1.3.2 Ovarian Cancer
1.3.3 Cervical Cancer
1.3.4 Breast Cancer
1.3.5 Others
1.4 Global Taxol Market Size Estimates and Forecasts
1.4.1 Global Taxol Revenue 2019-2030
1.4.2 Global Taxol Sales 2019-2030
1.4.3 Global Taxol Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Taxol Market Competition by Manufacturers
2.1 Global Taxol Sales Market Share by Manufacturers (2019-2024)
2.2 Global Taxol Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Taxol Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Taxol, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Taxol, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Taxol, Product Type & Application
2.7 Global Key Manufacturers of Taxol, Date of Enter into This Industry
2.8 Global Taxol Market Competitive Situation and Trends
2.8.1 Global Taxol Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Taxol Players Market Share by Revenue
2.8.3 Global Taxol Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Taxol Market Scenario by Region
3.1 Global Taxol Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Taxol Sales by Region: 2019-2030
3.2.1 Global Taxol Sales by Region: 2019-2024
3.2.2 Global Taxol Sales by Region: 2025-2030
3.3 Global Taxol Revenue by Region: 2019-2030
3.3.1 Global Taxol Revenue by Region: 2019-2024
3.3.2 Global Taxol Revenue by Region: 2025-2030
3.4 North America Taxol Market Facts & Figures by Country
3.4.1 North America Taxol Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Taxol Sales by Country (2019-2030)
3.4.3 North America Taxol Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Taxol Market Facts & Figures by Country
3.5.1 Europe Taxol Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Taxol Sales by Country (2019-2030)
3.5.3 Europe Taxol Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Taxol Market Facts & Figures by Region
3.6.1 Asia Pacific Taxol Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Taxol Sales by Region (2019-2030)
3.6.3 Asia Pacific Taxol Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Taxol Market Facts & Figures by Country
3.7.1 Latin America Taxol Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Taxol Sales by Country (2019-2030)
3.7.3 Latin America Taxol Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Taxol Market Facts & Figures by Country
3.8.1 Middle East and Africa Taxol Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Taxol Sales by Country (2019-2030)
3.8.3 Middle East and Africa Taxol Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Taxol Sales by Type (2019-2030)
4.1.1 Global Taxol Sales by Type (2019-2024)
4.1.2 Global Taxol Sales by Type (2025-2030)
4.1.3 Global Taxol Sales Market Share by Type (2019-2030)
4.2 Global Taxol Revenue by Type (2019-2030)
4.2.1 Global Taxol Revenue by Type (2019-2024)
4.2.2 Global Taxol Revenue by Type (2025-2030)
4.2.3 Global Taxol Revenue Market Share by Type (2019-2030)
4.3 Global Taxol Price by Type (2019-2030)
5 Segment by Application
5.1 Global Taxol Sales by Application (2019-2030)
5.1.1 Global Taxol Sales by Application (2019-2024)
5.1.2 Global Taxol Sales by Application (2025-2030)
5.1.3 Global Taxol Sales Market Share by Application (2019-2030)
5.2 Global Taxol Revenue by Application (2019-2030)
5.2.1 Global Taxol Revenue by Application (2019-2024)
5.2.2 Global Taxol Revenue by Application (2025-2030)
5.2.3 Global Taxol Revenue Market Share by Application (2019-2030)
5.3 Global Taxol Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Phyton
6.1.1 Phyton Company Information
6.1.2 Phyton Description and Business Overview
6.1.3 Phyton Taxol Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Phyton Taxol Product Portfolio
6.1.5 Phyton Recent Developments/Updates
6.2 ScinoPharm
6.2.1 ScinoPharm Company Information
6.2.2 ScinoPharm Description and Business Overview
6.2.3 ScinoPharm Taxol Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ScinoPharm Taxol Product Portfolio
6.2.5 ScinoPharm Recent Developments/Updates
6.3 Novasep
6.3.1 Novasep Company Information
6.3.2 Novasep Description and Business Overview
6.3.3 Novasep Taxol Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novasep Taxol Product Portfolio
6.3.5 Novasep Recent Developments/Updates
6.4 Samyang
6.4.1 Samyang Company Information
6.4.2 Samyang Description and Business Overview
6.4.3 Samyang Taxol Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Samyang Taxol Product Portfolio
6.4.5 Samyang Recent Developments/Updates
6.5 Polymed
6.5.1 Polymed Company Information
6.5.2 Polymed Description and Business Overview
6.5.3 Polymed Taxol Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Polymed Taxol Product Portfolio
6.5.5 Polymed Recent Developments/Updates
6.6 TAPI (Teva)
6.6.1 TAPI (Teva) Company Information
6.6.2 TAPI (Teva) Description and Business Overview
6.6.3 TAPI (Teva) Taxol Sales, Revenue and Gross Margin (2019-2024)
6.6.4 TAPI (Teva) Taxol Product Portfolio
6.6.5 TAPI (Teva) Recent Developments/Updates
6.7 Fresenius-kabi
6.7.1 Fresenius-kabi Company Information
6.7.2 Fresenius-kabi Description and Business Overview
6.7.3 Fresenius-kabi Taxol Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Fresenius-kabi Taxol Product Portfolio
6.7.5 Fresenius-kabi Recent Developments/Updates
6.8 Huiang biopharma
6.8.1 Huiang biopharma Company Information
6.8.2 Huiang biopharma Description and Business Overview
6.8.3 Huiang biopharma Taxol Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Huiang biopharma Taxol Product Portfolio
6.8.5 Huiang biopharma Recent Developments/Updates
6.9 Southpharma
6.9.1 Southpharma Company Information
6.9.2 Southpharma Description and Business Overview
6.9.3 Southpharma Taxol Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Southpharma Taxol Product Portfolio
6.9.5 Southpharma Recent Developments/Updates
6.10 Yunnan Hande
6.10.1 Yunnan Hande Company Information
6.10.2 Yunnan Hande Description and Business Overview
6.10.3 Yunnan Hande Taxol Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Yunnan Hande Taxol Product Portfolio
6.10.5 Yunnan Hande Recent Developments/Updates
6.11 Hainan Yew Pharm
6.11.1 Hainan Yew Pharm Company Information
6.11.2 Hainan Yew Pharm Description and Business Overview
6.11.3 Hainan Yew Pharm Taxol Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hainan Yew Pharm Taxol Product Portfolio
6.11.5 Hainan Yew Pharm Recent Developments/Updates
6.12 Jiangsu Yew Biotechnology
6.12.1 Jiangsu Yew Biotechnology Company Information
6.12.2 Jiangsu Yew Biotechnology Description and Business Overview
6.12.3 Jiangsu Yew Biotechnology Taxol Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jiangsu Yew Biotechnology Taxol Product Portfolio
6.12.5 Jiangsu Yew Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Taxol Industry Chain Analysis
7.2 Taxol Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Taxol Production Mode & Process
7.4 Taxol Sales and Marketing
7.4.1 Taxol Sales Channels
7.4.2 Taxol Distributors
7.5 Taxol Customers
8 Taxol Market Dynamics
8.1 Taxol Industry Trends
8.2 Taxol Market Drivers
8.3 Taxol Market Challenges
8.4 Taxol Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Taxol Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Taxol Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Taxol Market Competitive Situation by Manufacturers in 2023
Table 4. Global Taxol Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Taxol Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Taxol Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Taxol Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Taxol Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Taxol, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Taxol, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Taxol, Product Type & Application
Table 12. Global Key Manufacturers of Taxol, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Taxol by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Taxol as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Taxol Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Taxol Sales by Region (2019-2024) & (K Dose)
Table 18. Global Taxol Sales Market Share by Region (2019-2024)
Table 19. Global Taxol Sales by Region (2025-2030) & (K Dose)
Table 20. Global Taxol Sales Market Share by Region (2025-2030)
Table 21. Global Taxol Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Taxol Revenue Market Share by Region (2019-2024)
Table 23. Global Taxol Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Taxol Revenue Market Share by Region (2025-2030)
Table 25. North America Taxol Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Taxol Sales by Country (2019-2024) & (K Dose)
Table 27. North America Taxol Sales by Country (2025-2030) & (K Dose)
Table 28. North America Taxol Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Taxol Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Taxol Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Taxol Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Taxol Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Taxol Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Taxol Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Taxol Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Taxol Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Taxol Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Taxol Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Taxol Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Taxol Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Taxol Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Taxol Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Taxol Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Taxol Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Taxol Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Taxol Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East and Africa Taxol Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East and Africa Taxol Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Taxol Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Taxol Sales (K Dose) by Type (2019-2024)
Table 51. Global Taxol Sales (K Dose) by Type (2025-2030)
Table 52. Global Taxol Sales Market Share by Type (2019-2024)
Table 53. Global Taxol Sales Market Share by Type (2025-2030)
Table 54. Global Taxol Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Taxol Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Taxol Revenue Market Share by Type (2019-2024)
Table 57. Global Taxol Revenue Market Share by Type (2025-2030)
Table 58. Global Taxol Price (US$/Dose) by Type (2019-2024)
Table 59. Global Taxol Price (US$/Dose) by Type (2025-2030)
Table 60. Global Taxol Sales (K Dose) by Application (2019-2024)
Table 61. Global Taxol Sales (K Dose) by Application (2025-2030)
Table 62. Global Taxol Sales Market Share by Application (2019-2024)
Table 63. Global Taxol Sales Market Share by Application (2025-2030)
Table 64. Global Taxol Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Taxol Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Taxol Revenue Market Share by Application (2019-2024)
Table 67. Global Taxol Revenue Market Share by Application (2025-2030)
Table 68. Global Taxol Price (US$/Dose) by Application (2019-2024)
Table 69. Global Taxol Price (US$/Dose) by Application (2025-2030)
Table 70. Phyton Company Information
Table 71. Phyton Description and Business Overview
Table 72. Phyton Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Phyton Taxol Product
Table 74. Phyton Recent Developments/Updates
Table 75. ScinoPharm Company Information
Table 76. ScinoPharm Description and Business Overview
Table 77. ScinoPharm Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. ScinoPharm Taxol Product
Table 79. ScinoPharm Recent Developments/Updates
Table 80. Novasep Company Information
Table 81. Novasep Description and Business Overview
Table 82. Novasep Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Novasep Taxol Product
Table 84. Novasep Recent Developments/Updates
Table 85. Samyang Company Information
Table 86. Samyang Description and Business Overview
Table 87. Samyang Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Samyang Taxol Product
Table 89. Samyang Recent Developments/Updates
Table 90. Polymed Company Information
Table 91. Polymed Description and Business Overview
Table 92. Polymed Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Polymed Taxol Product
Table 94. Polymed Recent Developments/Updates
Table 95. TAPI (Teva) Company Information
Table 96. TAPI (Teva) Description and Business Overview
Table 97. TAPI (Teva) Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. TAPI (Teva) Taxol Product
Table 99. TAPI (Teva) Recent Developments/Updates
Table 100. Fresenius-kabi Company Information
Table 101. Fresenius-kabi Description and Business Overview
Table 102. Fresenius-kabi Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Fresenius-kabi Taxol Product
Table 104. Fresenius-kabi Recent Developments/Updates
Table 105. Huiang biopharma Company Information
Table 106. Huiang biopharma Description and Business Overview
Table 107. Huiang biopharma Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Huiang biopharma Taxol Product
Table 109. Huiang biopharma Recent Developments/Updates
Table 110. Southpharma Company Information
Table 111. Southpharma Description and Business Overview
Table 112. Southpharma Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Southpharma Taxol Product
Table 114. Southpharma Recent Developments/Updates
Table 115. Yunnan Hande Company Information
Table 116. Yunnan Hande Description and Business Overview
Table 117. Yunnan Hande Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. Yunnan Hande Taxol Product
Table 119. Yunnan Hande Recent Developments/Updates
Table 120. Hainan Yew Pharm Company Information
Table 121. Hainan Yew Pharm Description and Business Overview
Table 122. Hainan Yew Pharm Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. Hainan Yew Pharm Taxol Product
Table 124. Hainan Yew Pharm Recent Developments/Updates
Table 125. Jiangsu Yew Biotechnology Company Information
Table 126. Jiangsu Yew Biotechnology Description and Business Overview
Table 127. Jiangsu Yew Biotechnology Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 128. Jiangsu Yew Biotechnology Taxol Product
Table 129. Jiangsu Yew Biotechnology Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Taxol Distributors List
Table 133. Taxol Customers List
Table 134. Taxol Market Trends
Table 135. Taxol Market Drivers
Table 136. Taxol Market Challenges
Table 137. Taxol Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Taxol
Figure 2. Global Taxol Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Taxol Market Share by Type: 2023 & 2030
Figure 4. Natural Paclitaxel API Product Picture
Figure 5. Semi-synthetic Paclitaxel API Product Picture
Figure 6. Global Taxol Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Taxol Market Share by Application: 2023 & 2030
Figure 8. Ovarian Cancer
Figure 9. Cervical Cancer
Figure 10. Breast Cancer
Figure 11. Others
Figure 12. Global Taxol Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Taxol Market Size (2019-2030) & (US$ Million)
Figure 14. Global Taxol Sales (2019-2030) & (K Dose)
Figure 15. Global Taxol Average Price (US$/Dose) & (2019-2030)
Figure 16. Taxol Report Years Considered
Figure 17. Taxol Sales Share by Manufacturers in 2023
Figure 18. Global Taxol Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Taxol Players: Market Share by Revenue in Taxol in 2023
Figure 20. Taxol Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Taxol Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Taxol Sales Market Share by Country (2019-2030)
Figure 23. North America Taxol Revenue Market Share by Country (2019-2030)
Figure 24. United States Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Taxol Sales Market Share by Country (2019-2030)
Figure 27. Europe Taxol Revenue Market Share by Country (2019-2030)
Figure 28. Germany Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Taxol Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Taxol Revenue Market Share by Region (2019-2030)
Figure 35. China Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Taxol Sales Market Share by Country (2019-2030)
Figure 43. Mexico Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Taxol Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Taxol Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Taxol Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Taxol by Type (2019-2030)
Figure 53. Global Revenue Market Share of Taxol by Type (2019-2030)
Figure 54. Global Taxol Price (US$/Dose) by Type (2019-2030)
Figure 55. Global Sales Market Share of Taxol by Application (2019-2030)
Figure 56. Global Revenue Market Share of Taxol by Application (2019-2030)
Figure 57. Global Taxol Price (US$/Dose) by Application (2019-2030)
Figure 58. Taxol Value Chain
Figure 59. Taxol Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
